Several firms now use microbes to produce high value human milk oligosaccharides for infant formula. But could plants be a better production vehicle?
AgFunderNews (AFN) caught up with Totality Biosciences cofounder and CEO Leila Strickland, PhD (LS), and VP R&D Collin Barnum, PhD (CB) at Future Food-Tech in San Francisco to discuss the limitations of microbial HMO production, the potential of plan...
The strongest version of this narrative highlights a genuine innovation in addressing a critical gap in infant nutrition. HMOs are undeniably valuable for early-life development, and the current microbial fermentation method is limited in both cost and variety. Totality Biosciences' plant-based approach leverages agriculture’s scalability and existing infrastructure, offering a plausible path to lower costs and broader accessibility. The focus on soybeans, a well-established crop, and the potent...
